5:30 PM ET
10-Q
Financial Results
Yubo International Biotech Q3 2026 Results: Net Loss of $188K, Loss Narrows
Yubo International Biotech Ltd is a U.S. holding company operating in China through a Variable Interest Entity (VIE) structure focused on stem cell research and development. As of September 30, 2026, the company reported total cash of $9,465 and is classified as a non-accelerated filer and smaller reporting company.
- Key figure
- Net loss $188K